SSGB

Caron Products Names Tom Kroeger Global Director of Quality

Retrieved on: 
Thursday, October 27, 2022
List of life sciences, Incubator, Bio Products Laboratory, Health care, Growth, Goal, Shire (pharmaceutical company), Biopharma LLC, Industry, ARI, FDA, Business administration, Mount Vernon Nazarene University, GLS, Organization, Knowledge, Workflow, Education, Research, CEO, Multimedia, View, Bachelor of Business Administration, SSGB, Plasmapheresis, Leadership, Pharmaceutical industry, Medical device, Management, Waste management, Caron, Biotechnology, Quality

MARIETTA, Ohio, Oct. 27, 2022 /PRNewswire/ -- Caron Products and Services, Inc. ("Caron"), a leading provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell and gene therapy research, and academic research, today announced Tom Kroeger has joined Caron's Leadership Team as Global Director of Quality. Based in Northwest Ohio and reporting directly to the CEO, he will focus on advancing the organizations development of quality strategies with an emphasis on Global Quality Systems supporting Caron's continued growth across North America, Europe, and Asia.

Key Points: 
  • MARIETTA, Ohio, Oct. 27, 2022 /PRNewswire/ -- Caron Products and Services, Inc. ("Caron"),a leading provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell and gene therapy research, and academic research, today announced Tom Kroeger has joined Caron's Leadership Team as Global Director of Quality.
  • Tom brings extensive knowledge in quality systems design and implementation, specifically related to plasmapheresis and aseptic processing.
  • "I am excited to welcome Tom to the Caron organization.His strong background in quality assurance systemsand federal regulations will better position Caron to meet the ever-changing demands of both current and emerging markets," said Jay Hexamer, Caron President and CEO.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/caron-products-names-tom-kroege...
    SOURCE Caron Products and Services, Inc. ("Caron")

Envision Healthcare Provides Best Practices to Address America’s Devastating Opioid Epidemic

Retrieved on: 
Friday, September 30, 2022
Mental Health, Health, Other Health, General Health, Research, Science, Pharmaceutical, Envision Healthcare, National academy, Master of Science, COVID-19, MD, Addiction, Ophthalmology, Elective surgery, FASA, Prescription, Population, Senior, Health, Public policy, Drug overdose, Patient, District, Ownership, Gastroenterology, Neonatology, Abuse, Leadership, United States drug overdose death rates and totals over time, Anesthesiology, SSGB, Health care, Opioid use disorder, Pharmaceutical industry, Risk management

Envision Healthcare, a leading national medical group, released a comprehensive strategy to address Americas pervasive opioid epidemic.

Key Points: 
  • Envision Healthcare, a leading national medical group, released a comprehensive strategy to address Americas pervasive opioid epidemic.
  • In 2020 alone, opioids were involved in 68,630 overdose deaths nearly 75 percent of all drug overdose deaths.
  • Additionally, the marked expansion of illicitly manufactured, potent synthetic opioids has flooded the U.S. with lethal counterfeit opioid pain pills, increasing the danger of non-prescribed opioids.
  • We are pleased to provide a patient-focused strategy to help stop opioid misuse and abuse and save peoples lives.